Ramiro Jover

Valencia, VC 46010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway.

The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway.

Journal: Archives of toxicology

Published: May 14, 2026

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Journal: Archives of toxicology

Published: June 20, 2025

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 09, 2025

Unlocking liver physiology: comprehensive pathway maps for mechanistic understanding.

Unlocking liver physiology: comprehensive pathway maps for mechanistic understanding.

Journal: Frontiers in toxicology

Published: April 28, 2025

Mapping physiology: A systems biology approach for the development of alternative methods in toxicology.

Mapping physiology: A systems biology approach for the development of alternative methods in toxicology.

Journal: ALTEX

Published: December 24, 2024

The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis.

The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis.

Journal: Biomolecules

Published: October 08, 2024

A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.

A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.

Journal: Toxicology

Published: September 10, 2024

Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].

Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 24, 2024

Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients.

Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients.

Journal: International journal of molecular sciences

Published: May 20, 2024

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.

Journal: International journal of molecular sciences

Published: March 25, 2024

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Journal: Hepatology (Baltimore, Md.)

Published: March 23, 2024

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Journal: International journal of molecular sciences

Published: February 05, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026